Nanwei Medicine received the "Decision on Invalid Declaration Request Censorship"

On August 18, 2022, South Micro Medicine (688029.SH) issued an announcement on receiving the "Decision on Invasive Declaration Request".

Nanwei Medical Technology Co., Ltd. (hereinafter referred to as "Company") received the "Invalent Decision Requirement Decision" issued by the People's Republic of China (hereinafter referred to as "") on August 17, 2022 (hereinafter referred to as ""). The "one type of hemostatic clip" invention patent held by the company held by Zhuji Pengtian Medical Device Co., Ltd. (hereinafter referred to as "Zhuji Pengtian") was reviewed.

On August 16, 2021, the invalidation of the request Zhuji Pengtian with the company's "one hemostatic clip" (patent number: 201410222753.7) the rights requirements of the invention patent did not have creativity and other reasons to make invalid announcements. For details, please refer to the company on September 7, 2021 on the website of the Shanghai Stock Exchange (Announcement Number: 2021-044). "> Www.sse.com.cn)" Nanwei Medical Technology Co., Ltd. The company's announcement on receiving the "Notice of Validity Declaration" (announcement number: 2021-044).

After review and invalidation department review by the Patent Bureau, and sending the company to the "Decision Decision of the Invalid Declaration of Request", the specific situation is as follows:

Invalid announcement of the request: Zhuji Pengtian Medical Device Co., Ltd.

Patent owner: Nanwei Medical Technology Co., Ltd.

Involved in patent: The company owned "a hemostatic clip" (patent number: 201410222753.7) The invention patent on the invalidation request request the request of the invalidity of the above patent right to review the request of the invalidity of the patent right, and the reasons for the invalidation request did not support it. It is believed that the claims involved in patent 1 and subordinate claim 2-8 are creative, and therefore make the following decisions:

The claims submitted by the patent person on November 10, 2020 Maintain the validity of the patent right of invention No. 201410222753.7 on the basis of 1-8.

Due to Zhuji Pengtian (that is, the invalidation of the requestant) related products are suspected of infringing the company's invention patent "a hematopoietic clip" (patent number: 201410222753.7), in July 2020, the company issued an infringement lawsuit against Zhuji Pengtian and requested the court It was ordered to stop the manufacturing and sales of related infringements immediately, while compensating the company's economic loss of 1 million yuan. In August 2020, the Intermediate People's Court of Ningbo City, Zhejiang Province accepted the case, and made a judgment in September 2021 to determine the establishment of Zhuji Pengtian patent infringement, requiring it to immediately stop the manufacturing, sell and destroy related infringement products, and compensate the company's related losses Essence As of the date of this announcement, the relevant judgment has come into effect and implemented.

During the period, on August 19, 2020, Zhuji Pengtian's claim for the "one hemostatic clip" (patent number: 201410222753.7) invention patents did not have creativity to make invalid announcements on the grounds of creativity. On May 20, 2021, the company received the "Invalid Decision on Requirement Decision" to review the reasons for Zhuji Pengtian after reviewing the invalidation request made by Zhuji Pengtian and in the company. The claims submitted on November 10, 2020 maintain the company's invention patent rights involved in the invention of the case on the basis of 1-8. For details, please refer to the company disclosed by the company on May 22, 2021 on the website of the Shanghai Stock Exchange (announcement number: 2021-026). "> Www.sse.com.cn). Received the announcement of the "Invalid Announcement of Requesting Decision>" (Announcement Number: 2021-026).

This matter was the second time Zhuji Pengtian applied for an invalid announcement of the company's "one kind of hemostatic" patent after August 2020, and was not supported again.

In view of the two review decisions in May 2021 and August 2022, the company's invention patent "a hemostatic clip" (patent number: 20141022753.7) Maintaining is effective. Therefore, this matter will not have a negative impact on the company's daily production and operation, nor will it have a negative impact on the company's current and future profit and loss.

- END -